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doi:10.1016/j.gmbhs.2012.03.005Abstract In the present study, multiple chemotherapeutic agent-related genetic polymor-
phisms, including dihydropyrimidine dehydrogenase (DPD) IVS14þ1 G>A, UGT1A1 3156 G>A,
and UDP-glucuronosyltransferase (UGT)1A1 28 tandem repeats, were analyzed in patients with
colorectal cancer and studied in correlation with the clinical features of those patients. The
genotypes from 273 patients with stages IeIV colorectal cancer who underwent operations
were determined by means of polymerase chain reaction-restriction fragment length polymor-
phism. The results showed that the genotype distribution of DPD GG, UGT1A1 3156 GG, and
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Vascular invasion and genetic polymorphisms in CRC 29respectively. After analysis of the relationship between the genotypes and clinicopathological
data of the patients, a significant correlation was observed between vascular invasion in
patients with genetic polymorphisms ofDPDGG, UGT1A13156GG, and UGT1A1 28 repeat 5/6
or 6/6 (OR: 2.236, p Z 0.015). There was a statistical correlation between vascular invasion
and tumor invasion, lymph node metastasis, cancer stage, differentiation, perineural invasion,
and survival (all p < 0.05). The results of the present study highly suggest that DPDGG, UG-
T1A13156GG, and UGT1A1 28 repeat 5/6 or 6/6 genotypes and vascular invasion could be prog-
nostic factors for Taiwanese patients with colorectal cancer.
Copyright ª 2012, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Genetic polymorphisms in drug-metabolizing enzymes have
been linked to interindividual differences in the toxicity
and efficacy of medication.1 A pharmacogenetic approach
may be an innovative strategy for optimizing chemotherapy
in patients with advanced colorectal cancer. We analyzed
several chemotherapeutic agent-related genetic poly-
morphisms, including dihydropyrimidine dehydrogenase
(DPD) IVS14þ1 G>A, UGT1A1 3156 G>A, and UDP-
glucuronosyltransferase (UGT) 1A1 28tandem repeats in
Taiwanese colorectal cancer patients.2e6
Materials and methods
Consecutive 273 patients were prospectively enrolled in
surgical units in Taiwan. Patients were required to have
cytologically/histologically confirmed colorectal cancer
disease. Blood samples were collected from these patients
having stages IeIV colorectal cancer, and the DNA was
isolated. A polymerase chain reaction-restriction fragment
length polymorphism method was used to detect the
frequency of the genotypes in our population. The associ-
ations of each genetic polymorphism with clinicopatholog-
ical data of patients were further analyzed.
Results
Results showed that the genotype distribution of DPD GG,
UGT1A13156GG, andUGT1A128 tandemrepeats 5/6or6/6 in
Taiwanese subjects were 98.4%, 82.2%, and 80.6%, respec-
tively. When analyzed jointly, a significant correlation was
observed between vascular invasion in patients with genetic
polymorphisms ofDPDGG, UGT1A13156GG, and UGT1A1 28
repeat 5/6 or 6/6 (OR: 2.236, pZ 0.015). There was a statis-
tical correlation between vascular invasion and tumor inva-
sion, lymph node metastasis, cancer stage, differentiation,
perineural invasion, and survival (all p < 0.05).
Discussion
DPD is a critical enzyme in the catabolism of 5-fluorouracil
(5-FU), a drug frequently used in cancer therapy. One of
the possible causes of severe 5-FU toxicity is geneticpolymorphisms in the DPD gene, such as IVS14þ1 G > A.3
Irinotecan unexpectedly causes severe toxicity of leuko-
penia or diarrhea. It is metabolized to form active SN-38,
which is further conjugated and detoxified by UGT1A1
enzyme. Genetic polymorphisms of the UGT1A1 would
affect an interindividual variation of the toxicity by irino-
tecan via the alternation of bioavailability of SN-38.2
The results of the present study highly suggest that DPD
GG, UGT1A1 3156GG, and UGT1A1 28 repeat 5/6 or 6/6
genotypes and vascular invasion could be prognostic factors
for Taiwanese patients with colorectal cancer.
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